Adma Biologics reported $192.84M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Adma Biologics USD 192.84M 745K Jun/2026
Alnylam Pharmaceuticals USD 2.47B 6.56M Jun/2026
BioCryst Pharmaceuticals USD 395.4M 203K Jun/2026
Minerva Neurosciences USD 0 86.58M Sep/2024
Novavax USD 246.3M 200K Dec/2025
Omeros USD 403.72M 27.2M Jun/2024
Takeda JPY 4.42T 50.32B Jun/2026